Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Personalized Cell Therapy Market Between 2025 And 2029?
The personalized cell therapy market has seen substantial expansion in recent years. It is projected to grow from $17.11 billion in 2024 to $20.83 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 21.8%. This growth over the historic period is linked to increased awareness of personalized medicine, a rise in healthcare spending, more government initiatives, enhanced funding for clinical research, and an increase in neurological disorders.
The personalized cell therapy market is projected for substantial expansion in the coming years. It is set to grow to $46.24 billion in 2029, achieving a compound annual growth rate (CAGR) of 22.1%. This growth during the forecast period is primarily driven by an increase in clinical trials, the rising incidence of chronic illnesses, an expanding geriatric population, the growing prevalence of cancer, and the wider adoption of regenerative medicines. Prominent trends for the forecast period include technological advancements, the integration of AI, personalized vaccines, bioinformatics, and microfluidic technologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp
Which Drivers Are Supporting Growth Of The Personalized Cell Therapy Market?
The escalating occurrence of neurological disorders is projected to propel the expansion of the personalized cell therapy market moving forward. These conditions represent a collection of ailments affecting the brain, spinal cord, and nerves, often resulting in symptoms such as compromised motor function, cognitive impairments, and sensory disturbances. Neurological disorders are emerging due to an aging demographic, environmental stressors, and lifestyle shifts, all contributing to increased incidences of neurodegenerative diseases. Personalized cell therapy becomes essential for neurological disorders as it delivers customized treatments tailored to specific patient requirements, potentially aiding in the restoration of damaged neural tissue and enhancing outcomes in complex, individualized situations. For instance, in December 2022, the Parkinson Foundation, a US-based government organization, stated that the yearly incidence of Parkinson’s disease (PD) among older individuals is 50% higher than the current estimate of 60,000 cases. Additionally, forecasts suggest that 1.2 million more Americans will be living with Parkinson’s disease by 2030. Thus, the increasing prevalence of neurological disorders is stimulating the growth of the personalized cell therapy market.
What Are The Key Segments In The Personalized Cell Therapy Market?
The personalized cell therapymarket covered in this report is segmented –
1) By Cell Type: Lymphocytes; Mesenchymal Stem Cell; Hematopoietic Stem Cell; Other Cell Type
2) By Technique: Platelet Transfusions; Bone Marrow Transplantation; Packed Red Cell Transfusions; Organ Transplantation
3) By Application: Cardiovascular Diseases; Neurological Disorders; Inflammatory Diseases; Diabetes; Cancer; Other Applications
4) By End-User: Hospital; Homecare; Specialty Clinics; Other End-User
Subsegments:
1) By Lymphocytes: T Cells; Natural Killer (NK) Cells; Regulatory T Cells
2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs; Adipose Tissue-Derived MSCs; Umbilical Cord-Derived MSCs
3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells; Allogeneic Hematopoietic Stem Cells
4) By Other Cell Types: Dendritic Cells; Fibroblasts; Endothelial Cells
Which Ongoing Trends Are Expected To Shape The Personalized Cell Therapy Market Outlook?
Leading companies operating within the personalized cell therapy market are concentrating on forging strategic alliances to hasten the advancement and commercialization of innovative therapies. These collaborations enable firms to combine resources, expertise, and technologies, thereby enhancing research and development capabilities, streamlining clinical trials, and more efficiently navigating regulatory pathways. For instance, in October 2022, Century Therapeutics Inc., a US-based biotechnology company, partnered with Bristol Myers Squibb (BMS), a US-based biopharmaceutical company, to develop and commercialize allogeneic cell therapies. This partnership utilizes Century’s innovative induced pluripotent stem cell (iPSC) technology to create engineered natural killer (NK) and T cell therapies for treating hematologic malignancies and solid tumors. The agreement encompasses the development of up to four distinct cell therapy programs, with the initial focus on two specific areas: acute myeloid leukemia (AML) and multiple myeloma. These programs are set to utilize engineered NK cells or gamma delta T cells derived from iPSCs.
Who Are The Major Companies Operating In The Personalized Cell Therapy Market?
Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report
What Are The Key Regional Factors Influencing The Personalized Cell Therapy Market Growth?
North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Personalized Cell Therapy Market Report:
https://www.thebusinessresearchcompany.com/customise?id=19137&type=smp
Browse Through More Reports Similar to the Global Personalized Cell Therapy Market 2025, By The Business Research Company
Cells Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Stem Cells Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Cell Therapy Technologies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model